Th17/IL-17 may promote ferroptosis through modulation of the TP53/Nrf2 signaling axis in acute-on-chronic liver failure

Ye Liu, Zihong Bao, Ju Zhou, Dingchun Li, Wu Li

Open source

DOI
10.5114/ceh.2026.164208
Published
2026
Container
Clinical and Experimental Hepatology
Publisher
Termedia Sp. z.o.o.
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.5114/ceh.2026.164208,
  title = {Th17/IL-17 may promote ferroptosis through modulation of the TP53/Nrf2 signaling axis in acute-on-chronic liver failure},
  author = {Ye Liu and Zihong Bao and Ju Zhou and Dingchun Li and Wu Li},
  year = {2026},
  journal = {Clinical and Experimental Hepatology},
  doi = {10.5114/ceh.2026.164208},
  url = {https://doi.org/10.5114/ceh.2026.164208}
}

RIS

TY  - JOUR
TI  - Th17/IL-17 may promote ferroptosis through modulation of the TP53/Nrf2 signaling axis in acute-on-chronic liver failure
AU  - Ye Liu
AU  - Zihong Bao
AU  - Ju Zhou
AU  - Dingchun Li
AU  - Wu Li
PY  - 2026
JO  - Clinical and Experimental Hepatology
DO  - 10.5114/ceh.2026.164208
UR  - https://doi.org/10.5114/ceh.2026.164208
ER  - 

APA

Liu, Y., Bao, Z., Zhou, J., Li, D., & Li, W. (2026). Th17/IL-17 may promote ferroptosis through modulation of the TP53/Nrf2 signaling axis in acute-on-chronic liver failure. Clinical and Experimental Hepatology. https://doi.org/10.5114/ceh.2026.164208

Source records